USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 157 filers reported holding USANA HEALTH SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -20.0% | 64 | -11.1% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +66.7% | 72 | +20.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 60 | +33.3% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 45 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 45 | +2.3% | 0.00% | – |
| Q4 2021 | $4,000 | -99.8% | 44 | -99.8% | 0.00% | -100.0% |
| Q2 2020 | $1,799,000 | +350.9% | 24,500 | +255.1% | 0.01% | +200.0% |
| Q1 2020 | $399,000 | -45.9% | 6,900 | -26.6% | 0.00% | 0.0% |
| Q4 2019 | $738,000 | +14.8% | 9,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $643,000 | -62.9% | 9,400 | -56.9% | 0.00% | -66.7% |
| Q2 2019 | $1,732,000 | -24.6% | 21,800 | -20.4% | 0.01% | -33.3% |
| Q1 2019 | $2,298,000 | -10.9% | 27,400 | +25.1% | 0.01% | -18.2% |
| Q4 2018 | $2,578,000 | +73.8% | 21,900 | +78.0% | 0.01% | +83.3% |
| Q3 2018 | $1,483,000 | -2.6% | 12,300 | -6.8% | 0.01% | 0.0% |
| Q2 2018 | $1,522,000 | +34.2% | 13,200 | 0.0% | 0.01% | +50.0% |
| Q1 2018 | $1,134,000 | +18.7% | 13,200 | +2.3% | 0.00% | 0.0% |
| Q4 2017 | $955,000 | +2.8% | 12,900 | -19.9% | 0.00% | 0.0% |
| Q3 2017 | $929,000 | -5.9% | 16,100 | +4.5% | 0.00% | 0.0% |
| Q2 2017 | $987,000 | +11.3% | 15,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $887,000 | -5.8% | 15,400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $942,000 | -11.5% | 15,400 | +100.0% | 0.00% | -20.0% |
| Q3 2016 | $1,065,000 | -2.3% | 7,700 | -9.8% | 0.01% | -16.7% |
| Q4 2015 | $1,090,000 | -4.7% | 8,532 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $1,144,000 | +38.5% | 8,532 | -23.9% | 0.01% | +250.0% |
| Q3 2014 | $826,000 | -5.7% | 11,210 | 0.0% | 0.00% | -60.0% |
| Q2 2014 | $876,000 | +3.7% | 11,210 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $845,000 | -0.2% | 11,210 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $847,000 | -12.9% | 11,210 | 0.0% | 0.01% | -25.0% |
| Q3 2013 | $973,000 | – | 11,210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |